OTC Healthcare in Lithuania
Euromonitor International's OTC Healthcare in Lithuania market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 101 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Deteriorating Economic Climate Slows Down OTC Healthcare's Development
The Lithuanian OTC healthcare market continued to grow in 2008, albeit at a much slower rate than in previous years of the review period. Like other industries, OTC healthcare has started to feel the impact from the deteriorating economic environment in Lithuania. High inflation has reduced consumer purchasing power. OTC healthcare is relatively less dependent on the economic situation as people will always get ill. However, the slowdown has been caused by consumer preference for cheaper medicines and reduced consumption of non-essential OTC products.
Average Unit Price Is Rising
In 2008 the average unit price of OTC medicines in Lithuania rose as the manufacturing and logistics costs of all medicines increased due to high inflation. Pharmaceutical companies were unable to increase the prices of the majority of RX medicines as these are fixed and regulated by the state. This led to them raising the prices of OTC medicines, which were supposed to compensate for the higher manufacturing costs of all products. Pharmaceutical companies' influence on doctors and pharmacists and strong advertising campaigns are driving the popularity of more expensive products. In addition, it has been noticed that some pharmacies are removing some of the cheapest products from their shelves as the margins on these products are low. If this trend spreads, average unit price will rise even more. However, unit price growth has not been that significant as pharmaceutical companies have had to consider declining consumer purchasing power and strong competition in the marketplace.
Advertising Helps Multinationals to Dominate the Market
Advertising remains the key to success for OTC products. The most advertised medicines in Lithuania were also some of the most successful in terms of value sales. Consistent advertising over long periods made the digestive remedy Mezym an essential product in almost every household. The importance of advertising is more beneficial to large multinational pharmaceutical companies as they usually have huge marketing budgets, which help them to dominate the biggest sectors. Domestic producers are left with smaller, niche sectors, where their products are historically popular.
Chemists/Pharmacies Reaches Saturation
There were no major changes in OTC distribution in 2008. Chemists/pharmacies remained the only places where OTC products, except for vitamins, can be bought. The number of pharmacies in Lithuania has reached saturation point. The relatively high number of pharmacies created an intense competitive environment which led to around a quarter of them being unprofitable. As a result, the channel has seen a period of consolidation. Despite being available in parapharmacies/drugstores and supermarkets, chemists/pharmacies remains the major distribution channel for vitamins and dietary supplements as only here can consumers receive qualified advice.
Further Market Development Hampered by Economic Problems
The OTC healthcare market will continue to grow over the forecast period as demand for drugs will continue to rise. The main market drivers will be the ageing population, busier and more stressful lifestyles, increased consumer health awareness and demand for modern medicines. Driven partly by advertising, the growing self- medication trend will also underpin OTC sales. However, the difficult economic environment will significantly hinder the market's performance as a decline in purchasing power will mean consumers will purchase only essential and cheaper OTC products. This trend will be at its strongest in the early part of the forecast period.
Table of contents
OTC HEALTHCARE IN LITHUANIA : MARKET INSIGHT
EXECUTIVE SUMMARY
Deteriorating Economic Climate Slows Down OTC Healthcare's Development
Average Unit Price Is Rising
Advertising Helps Multinationals to Dominate the Market
Chemists/Pharmacies Reaches Saturation
Further Market Development Hampered by Economic Problems
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2008
DEFINITIONS
Summary 2 Research Sources
SANITAS AB
Strategic Direction
Key Facts
Summary 3 Sanitas AB: Key Facts
Summary 4 Sanitas AB (Without Group Companies): Operational Indicators 2005-2007
Company Background
Production
Summary 5 Sanitas AB: Production Statistics 2007
Competitive Positioning
Summary 6 Sanitas AB: Competitive Position 2008
SICOR BIOTECH UAB
Strategic Direction
Key Facts
Summary 7 SICOR Biotech UAB: Key Facts
Summary 8 SICOR Biotech UAB: Operational Indicators 2005-2007
Company Background
Production
Competitive Positioning
VALENTIS UAB
Strategic Direction
Key Facts
Summary 9 Valentis UAB: Key Facts
Summary 10 Valentis UAB: Operational Indicators 2005-2007
Company Background
Production
Competitive Positioning
Summary 11 Valentis UAB: Competitive Position 2008
ANALGESICS
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 11 Sales of Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Topical Analgesics 2003-2008
Table 14 Analgesics Company Shares by Value 2004-2008
Table 15 Analgesics Brand Shares by Value 2005-2008
Table 16 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 20 Sales of Decongestants by Type: Value 2003-2008
Table 21 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 22 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 24 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 25 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 27 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 29 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 30 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 31 Herbal vs Standard Digestive Remedies 2003-2008
Table 32 Digestive Remedies Company Shares by Value 2004-2008
Table 33 Digestive Remedies Brand Shares by Value 2005-2008
Table 34 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 35 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 36 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 37 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 38 Herbal vs Standard Medicated Skin Care 2003-2008
Table 39 Medicated Skin Care Company Shares by Value 2004-2008
Table 40 Medicated Skin Care Brand Shares by Value 2005-2008
Table 41 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 42 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 43 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 44 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 45 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 46 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 47 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 48 Vitamins Brand Shares by Value 2005-2008
Table 49 Dietary Supplements Brand Shares by Value 2005-2008
Table 50 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 51 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Indicators
Table 52 Number of Smokers by Gender 2003-2008
Sector Data
Table 53 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 54 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 55 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 56 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 57 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 58 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE
Overview
Sector Data
Table 59 Sales of Eye Care by Subsector: Value 2003-2008
Table 60 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 61 Eye Care Company Shares by Value 2004-2008
Table 62 Eye Care Brand Shares by Value 2005-2008
Table 63 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 64 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
WOUND TREATMENTS
Overview
Sector Data
Table 65 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 66 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 67 Wound Treatments Company Shares by Value 2004-2008
Table 68 Wound Treatments Brand Shares by Value 2005-2008
Table 69 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 70 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
EAR CARE
Overview
Sector Data
Table 71 Sales of Ear Care: Value 2003-2008
Table 72 Sales of Ear Care: % Value Growth 2003-2008
Table 73 Ear Care Company Shares by Value 2004-2008
Table 74 Ear Care Brand Shares by Value 2005-2008
Table 75 Forecast Sales of Ear Care: Value 2008-2013
Table 76 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE
Headlines
Sector Data
Table 77 Sales of Adult Mouth Care: Value 2003-2008
Table 78 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 79 Adult Mouth Care Company Shares by Value 2004-2008
Table 80 Adult Mouth Care Brand Shares by Value 2005-2008
Table 81 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 82 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS
Overview
Sector Data
Table 83 Sales of Calming and Sleeping Products: Value 2003-2008
Table 84 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 85 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 86 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 87 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 88 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
EMERGENCY CONTRACEPTION
Overview
OTC OBESITY
Overview
Sector Data
Table 89 Forecast Sales of OTC Obesity: Value 2010-2013
Table 90 Forecast Sales of OTC Obesity: % Value Growth 2010-2013
OTC TRIPTANS
Overview